Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins
Condition(s):Chronic Hepatitis BLast Updated:August 19, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Chronic Hepatitis BLast Updated:August 19, 2022Recruiting
Condition(s):Burn ShockLast Updated:November 15, 2022Completed
Condition(s):COVID19Last Updated:May 12, 2020Unknown status
Condition(s):Inflammatory Bowel Diseases; Ulcerative Colitis; Crohn DiseaseLast Updated:August 12, 2022Recruiting
Condition(s):Immunoglobulin E-Mediated Food Allergy; Immunoglobulin G4-Related Disease; Symptoms and Signs; Adverse Reaction to FoodLast Updated:January 12, 2023Recruiting
Condition(s):Guillain-Barre SyndromeLast Updated:October 10, 2022Not yet recruiting
Condition(s):Covid19Last Updated:October 5, 2020Unknown status
Condition(s):Covid-19; Subjects Vaccinated Against Covid-19Last Updated:August 29, 2022Recruiting
Condition(s):CIDP – Chronic Inflammatory Demyelinating PolyneuropathyLast Updated:October 19, 2020Recruiting
Condition(s):SARS-CoV-2Last Updated:September 16, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.